Rentsch, Cyrill A

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 14.

Journal Article

Vlajnic, Tatjana; Müller, David C; Ruiz, Christian; Schönegg, René; Seifert, Hans-Helge; Thalmann, George N; Zellweger, Tobias; Le Magnen, Clémentine; Rentsch, Cyrill A; Bubendorf, Lukas (2023). Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer. (In Press). Cancer reports, 7(2), e1953. Wiley 10.1002/cnr2.1953

Rentsch, Cyrill A; Thalmann, George N; Lucca, Ilaria; Kwiatkowski, Maciej; Wirth, Grégory J; Strebel, Räto T; Engeler, Daniel; Pedrazzini, Augusto; Hüttenbrink, Clemens; Schultze-Seemann, Wolfgang; Torpai, Raimund; Bubendorf, Lukas; Wicki, Andreas; Roth, Beat; Bosshard, Piet; Püschel, Heike; Boll, Daniel T; Hefermehl, Lukas; Roghmann, Florian; Gierth, Michael; ... (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European urology oncology, 5(2), pp. 195-202. Elsevier 10.1016/j.euo.2021.12.006

Servant, Raphaëlle; Garioni, Michele; Vlajnic, Tatjana; Blind, Melanie; Pueschel, Heike; Müller, David C; Zellweger, Tobias; Templeton, Arnoud J; Garofoli, Andrea; Maletti, Sina Laura; Piscuoglio, Salvatore; Rubin, Mark A.; Seifert, Helge; Rentsch, Cyrill A; Bubendorf, Lukas; Le Magnen, Clémentine (2021). Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. The journal of pathology, 254(5), pp. 543-555. Wiley 10.1002/path.5698

Rentsch, Cyrill A; Bosshard, Piet; Mayor, Grégoire; Rieken, Malte; Püschel, Heike; Wirth, Grégory; Cathomas, Richard; Parzmair, Gerald P; Grode, Leander; Eisele, Bernd; Sharma, Hitt; Gupta, Manish; Gairola, Sunil; Shaligram, Umesh; Goldenberger, Daniel; Spertini, François; Audran, Régine; Enoiu, Milica; Berardi, Simona; Hayoz, Stefanie; ... (2020). Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy. Oncoimmunology, 9(1), p. 1748981. Taylor & Francis 10.1080/2162402X.2020.1748981

Rentsch, Cyrill A; Derré, Laurent; Dugas, Sarah G; Wetterauer, Christian; Federer-Gsponer, Joël R; Thalmann, George; Ingersoll, Molly A (2018). Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy. European urology focus, 4(4), pp. 485-493. Elsevier 10.1016/j.euf.2018.10.010

Mason, Malcolm D; Clarke, Noel W; James, Nicholas D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Attard, Gerhardt; Cross, William; Jones, Rob J; Parker, Christopher C; Russell, J Martin; Thalmann, George; Schiavone, Francesca; Cassoly, Estelle; Matheson, David; Millman, Robin; Rentsch, Cyrill A; Barber, Jim; Gilson, Clare; Ibrahim, Azman; ... (2017). Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. Journal of clinical oncology, 35(14), pp. 1530-1541. American Society of Clinical Oncology 10.1200/JCO.2016.69.0677

Ghadjar, Pirus; Oesch, Sebasian; Rentsch, Cyrill A; Isaak, Bernhard; Cihoric, Nikola; Manser, Peter; Thalmann, George; Aebersold, Daniel (2014). Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer. Radiation oncology, 9, p. 122. BioMed Central 10.1186/1748-717X-9-122

Biot, Claire; Rentsch, Cyrill A; Gsponer, Joel R; Birkhäuser, Frédéric D; Jusforgues-Saklani, Hélène; Lemaître, Fabrice; Auriau, Charlotte; Bachmann, Alexander; Bousso, Philippe; Demangel, Caroline; Peduto, Lucie; Thalmann, George N; Albert, Matthew L (2012). Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Science translational medicine, 4(137), 137ra72. Washington, D.C.: American Association for the Advancement of Science 10.1126/scitranslmed.3003586

Ruiz, Christian; Oeggerli, Martin; Germann, Markus; Gluderer, Silvia; Stocker, Hugo; Andreozzi, Mariacarla; Thalmann, George N; Cecchini, Marco G; Zellweger, Tobias; Stürm, Susanna; Koivisto, Pasi A; Helin, Heikki J; Gelmann, Edward P; Glass, Andrew G; Gasser, Thomas C; Terracciano, Luigi M; Bachmann, Alexander; Wyler, Stephen; Bubendorf, Lukas and Rentsch, Cyrill A (2012). High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. Prostate, 72(15), pp. 1678-87. Hoboken, N.J.: Wiley-Blackwell 10.1002/pros.22521

Ghadjar, Pirus; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Thalmann, George N; Aebersold, Daniel M (2011). Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Brachytherapy, 10(4), pp. 286-94. New York, N.Y.: Elsevier

Karamitopoulou, Eva; Rentsch, Cyrill A; Markwalder, Regula; Vallan, Claudio; Thalmann, George N; Brunner, Thomas (2010). Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens. Pathology, 42(1), pp. 37-42. London: Wolters Kluwer Lippincott Williams & Wilkins 10.3109/00313020903434397

Ghadjar, Pirus; Matzinger, Oscar; Isaak, Bernhard; Behrensmeier, Frank; Stroux, Andrea; Rentsch, Cyrill A; Thalmann, George N; Aebersold, Daniel M (2009). Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Radiotherapy and oncology, 91(2), pp. 237-42. Amsterdam: Elsevier 10.1016/j.radonc.2008.12.007

Ghadjar, Pirus; Keller, Tamara; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Stroux, Andrea; Thalmann, George N; Aebersold, Daniel M (2009). Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy, 8(1), pp. 45-51. New York, N.Y.: Elsevier 10.1016/j.brachy.2008.09.004

Rentsch, Cyrill A; Cecchini, Marco G; Schwaninger, Ruth; Germann, Markus; Markwalder, Regula; Heller, Manfred; van der Pluijm, Gabri; Thalmann, George N; Wetterwald, Antoinette (2006). Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer. International journal of cancer, 118(4), pp. 899-906. Malden, Mass.: Wiley-Blackwell 10.1002/ijc.21449

This list was generated on Fri Apr 19 02:05:40 2024 CEST.
Provide Feedback